Prevalence of prader-willi syndrome in Western India by Pankaj K. Gadhia, Salil N. Vaniawala
684
Pankaj et al., Int J Med Res Health Sci. 2014;3(3):684-686
International Journal of Medical Research
&
Health Sciences
www.ijmrhs.com Volume 3 Issue 3 Coden: IJMRHS Copyright @2014 ISSN: 2319-5886
Received: 9
th Apr 2014 Revised: 5
th May 2014 Accepted: 16
thMay 2014
Short communication
PREVALENCE OF PRADER-WILLI SYNDROME IN WESTERN INDIA
*Pankaj  K. Gadhia, Salil N. Vaniawala
Molecular Cytogenetic Unit, S N. Gene Laboratory and Research Centre, President Plaza A, Near RTO circle,
Surat, India
* Corresponding author email: pankajkgadhia@gmail.com
ABSTRACT
The prevalence of Prader-Willi Syndrome (PWS) was studied using both classic cytogenetic and FISH techniques
in referred cases of microdeletion 15q11-13 to our laboratory from Western India.  A total of 53 cases were
registered,  of  which  08(15%)  were  found  positive  for  Prader-Willi  Syndrome  i.e.  15q11-13  microdeletion
syndrome. FISH technique found to be suitable and sensitive to confirm clinically diagnosed PWS.
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INTRODUCTION
Prader-Willi  syndrome  (PWS)  is  a  complex
multisystem disorder due to the absent expression of
the  paternally  active  genes  in  PWS  region on
chromosome 15.
1 In 75 to 80% of affected individuals
there  is a microdeletion  of  paternal  chromosome
15q11-13.
2 PWS is a  complex  genetic  disorder
attributed  to  genomic  imprinting.    It  is  relatively
common prevalence of 1/15,000 – 30,000.  Despite
genetic  cause  it  appears  to  be  sporadic,  sex-ratio
equals  and  occurs  in  all races.
3,4 The  differential
diagnosis  includes  obesity,  cryptorchidism,  short
stature, mental retardation, sleep apnoea and squint
myopia.
The  microdeletion  syndrome  is  characterised  by
hemizygous microdeletion  less  than  5  mb  of
chromosome in which one or group of genes are lost.
5
G-banded karyotyping is approach to detect genomic
resolution more than 5 mb. This resolution has been
overcome by FISH.  It is possible to detect cryptic
chromosomal rearrangement such as microdeletion by
conventional FISH technique.
MATERIALS AND METHODS
The study was conducted at S. N. Gene Laboratory
and  Research  Centre,  Surat,  India  between  August
2010  and  February  2014.    A  total  of  53  suspected
cases  were  refereed  to  us  from  different  parts  of
Western  India and  inform consent  form was  taken
from all the subjects. From all patients EDTA and
heparinised blood sample (1 – 2 ml.) were collected
and were cultured for 72-hours by standard method
developed by Moorehead et al.
6 The karyotypes were
examined  using  GTG  banding  and the  automatic
scanning  system  (Axioimager  Z2–Carl-Zeiss)  and
karyotyping software (IKAROS, Germany) was used
to  make  karyotype. Fluorescence  in  situ
hybridization  (FISH)  was  carried  out in both
interphase  cells  and  metaphases  by using Vysis
probes of  LSI  SNRPN  and  D15S10  Prader-
Willi/Angelman.  The LSI  D15S10  probes identify
deletion  of  the  locus  D15S10  and  UBE3A  gene
located within 15q11-13 region of chromosome 15.
The procedure was performed as per instruction given
by manufacturer. From each patient minimum of 25
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interphase cells and 25 metaphases or 50 metaphases
were scored and analysed for presence or absence of
15q11-13 microdeletion.
RESULTS AND DISCUSSION
A total of 53 patients clinically diagnosed as Prader-
Willi  syndrome (PWS) were  referred  to  us  for
chromosome  study  and  FISH  analysis.  Out  of  53
patients, 30 were males and 23 females ranging in age
from 8 days to 41 years. G-banded karyotypes of all
patients did not show any deletion on chromosome #
15. Only 08  (15%)  patients  (Table-1) confirmed
positive with microdeletion (Figs. 2,3) of 15q11-13
by  FISH  analysis. Prader-Willisyndrome  is  single
most commonly known genetic cause of obesity. It
has been estimated to have a population prevalence
about  1:10,000  to  1:52,000  as  reported  by
Whittington et al.,
7.In large database population study
was  carried  out  by  Grugni  et  al.,
4on  the  Italian
National survey for Prader-Willi syndrome.
Table: 1 shows age and sex distribution among confirmed Prader-Willi syndrome
Patients no. Age Sex FISH result Deletion
1 4 Years M 20 metaphases and 20 interphase cells with microdeletion 15q11-13
2 1 year M 25 metaphases and 25 interphase cells with microdeletion 15q11-13
3 8 years M 50 metaphases with microdeletion 15q11-13
4 7 years M 25 metaphases and 25 interphase cells with microdeletion 15q11-13
5 6 years M 25 metaphases and 25 interphase cells with microdeletion 15q11-13
6 2 years M 50  metaphases with microdeletion 15q11-13
7 3 years M 50 metaphases  with microdeletion 15q11-13
8 2 years F 25 metaphases and 25 interphase cells with microdeletion 15q11-13
Fig 1:  G-banded karyotype of male patient shows
no deletion in chromosome # 15
Fig 2: Metaphase showing 2 green and one orange
signals confirming micro deletion of 15q11-13
Fig  3:  Interphase  cell  showing  2  green  and  1
orange confirming micro deletion of 15q11-13
The study revealed; out of 425 subjects del 15 was
found in 238 cases. It is generally known that PWS
patients developed morbid obesity
.8
The  complications associated  with  obesity  are  the
main risk factor for the death in PWS
9.
In the present study, we found only one older person
with age of 41 years.  Rest of all patients were under
age of 12 years.  In addition, it is interesting to note
that out of 08 affected patients, 07 were males and
only  one  female (Table-1).  On  the  contrary, few
published  studies  have  reported  that  PWS  affects
males and females equally
,10,11.  In another study from
India, Halder et al.,
5 has reported 4 positive cases (2
pure  and  2  mosaic)  out  of  38  patients  studied for686
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suspected Prader-Willi/Angelman  syndrome.    They
have further suggested that whole genome screening
may be used as a first line of test and FISH may be
used for confirmation of screening results.
CONCLUSION
In conclusion, we propose that routine use of FISH
for  diagnosis  of  microdeletion  of  15q11-13  is
considered  to  be a gold  standard  technique  which
confirm accurately done diagnosis of microdeletion in
general and Prader-Willi syndrome in particular.
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